Biotech Values

[vinmantoo]

Yes - but I hope they continue to work on it. Covid is here to stay in some capacity for years (maybe forever?), and it sure would be nice to have a pill to take. A good DAA would be a big seller even if covid has low prevalence due to concerns about long term effects even in people w "mild" illness

Actually, given ENTA's expertise in anti-virals, I think their COVID-19 drugs have a better shot to succeed than NASH. The target is much better defined, the need will remain for quite some time and the readout for success will be quite rapid. The latter means ENTA won't waste much cash on a failed program. I increased my shares of ENTA by 10% last week and may do so again. Too bad I missed the dip to $43.38 this morning at that was before I got up.